Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO - Thailand Business News

BEIJING and SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets,

Related Keywords

Shanghai ,China ,United States ,Thailand ,Chicago ,Illinois ,Jun Zhao ,Henan ,Boston ,Massachusetts ,Beijing ,Chinese ,American ,Jacobio Pharma ,Jie Wang ,Yuankai Shi ,Andrea Gillam Wang ,Cancer Hospital Chinese Academy Of Medical Sciences ,American Society Of Clinical Oncology ,Clinical Oncology ,Annual Meeting ,Professor Jun Zhao ,Beijing Cancer Hospital ,Chief Medical Officer ,Global Head ,Priority Review ,Professor Yuankai Shi ,Cancer Hospital Chinese Academy ,Medical Sciences ,Induced Allosteric Drug Discovery Platform ,Jacobio Pharma Presents ,Thailand Business ,